{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T22:46:05Z","timestamp":1786833965981,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12889-018-5298-8","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:05:58Z","timestamp":1522811158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Varicella in Poland: economic burden in children 1\u201312\u00a0years of age in Poland, 2010\u20132015"],"prefix":"10.1186","volume":"18","author":[{"given":"Jacek","family":"Wysocki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Malecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Stryczynska-Kazubska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Rampakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara J.","family":"Wolfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"issue":"3","key":"5298_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","volume":"9","author":"AM Arvin","year":"1996","unstructured":"Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361\u201381.","journal-title":"Clin Microbiol Rev"},{"key":"5298_CR2","unstructured":"Whitley RJ. Varicella-zoster virus infections. In: Galasso GJ, Whitley RJ, Merigan TC, editors. Antiviral agents and viral diseases of man. New York, New York: Raven Press; 1990.2012. p. 235\u201363."},{"issue":"2","key":"5298_CR3","first-page":"99","volume":"19","author":"R Manfredi","year":"1997","unstructured":"Manfredi R, Chiodo F, Titone L, Vierucci A, Catania S, Ghirardini G, et al. Chickenpox complications among immunocompetent hospitalized children in Italy. Acyclovir-chickenpox Italian study group. Pediatr Med Chir. 1997;19(2):99\u2013104.","journal-title":"Pediatr Med Chir"},{"issue":"6","key":"5298_CR4","first-page":"614","volume":"53","author":"H Ozdemir","year":"2011","unstructured":"Ozdemir H, Candir MO, Karbuz A, Belet N, Tapisiz A, Ciftci E, et al. Chickenpox complications, incidence and financial burden in previously healthy children and those with an underlying disease in Ankara in the pre-vaccination period. Turk J Pediatr. 2011;53(6):614\u201325.","journal-title":"Turk J Pediatr"},{"issue":"5","key":"5298_CR5","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1542\/peds.108.5.e79","volume":"108","author":"C Ziebold","year":"2001","unstructured":"Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001;108(5):E79.","journal-title":"Pediatrics"},{"issue":"12","key":"5298_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/INF.0b013e31826ff3a5","volume":"31","author":"A Bardach","year":"2012","unstructured":"Bardach A, Cafferata ML, Klein K, Cormick G, Gibbons L, Ruvinsky S. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean-a systematic review and meta-analysis. Pediatr Infect Dis J. 2012;31(12):1263\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"9544","key":"5298_CR7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365\u201376.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"5298_CR8","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1086\/522163","volume":"197","author":"C Sadzot-Delvaux","year":"2008","unstructured":"Sadzot-Delvaux C, Rentier B, Wutzler P, Asano Y, Suga S, Yoshikawa T, et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis. 2008;197(Suppl 2):S185\u2013S90.","journal-title":"J Infect Dis"},{"issue":"13","key":"5298_CR9","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1017\/S0950268817001546","volume":"145","author":"K Bollaerts","year":"2017","unstructured":"Bollaerts K, Riera-Montes M, Heininger U, Hens N, Souverain A, Verstraeten T, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect. 2017;145(13):2666\u201377.","journal-title":"Epidemiol Infect"},{"key":"5298_CR10","volume-title":"Zachorowania na wybrane choroby zaka\u017ane w Polsce od 1 stycznia do 31 grudnia 2015 r. oraz w por\u00f3wnywalnym okresie","author":"Zak\u0142ad Epidemiologii NIZP-PZH (Departament Zapobiegania oraz Zwalczania Zaka\u017ce\u0144 i Chor\u00f3b Zaka\u017anych u Ludzi GIS)","year":"2014","unstructured":"Zak\u0142ad Epidemiologii NIZP-PZH (Departament Zapobiegania oraz Zwalczania Zaka\u017ce\u0144 i Chor\u00f3b Zaka\u017anych u Ludzi GIS). Zachorowania na wybrane choroby zaka\u017ane w Polsce od 1 stycznia do 31 grudnia 2015 r. oraz w por\u00f3wnywalnym okresie 2014. Available from: http:\/\/wwwold.pzh.gov.pl\/oldpage\/epimeld\/2015\/INF_15_12B.pdf ."},{"key":"5298_CR11","unstructured":"Narodowy Instytut Zdrowia Publicznego, Pan\u2019stwowy Zak\u0142ad Higieny, Zak\u0142ad Epidemiologii; G\u0142\u00f3wny Inspektorat Sanitarny, Departament Zapobiegania oraz Zwalczania Zakaz \u02d9en \u2032 i Chor\u00f3b Zakaz\u2019nych u Ludzi. CHOROBY ZAKAZ \u2032NE I ZATRUCIA W POLSCE W 2014 ROKU. Available from: wwwold.pzh.gov.pl\/oldpage\/epimeld\/2014\/Ch_2014.pdf . Accessed 12 Feb 2016."},{"issue":"4","key":"5298_CR12","first-page":"495","volume":"63","author":"J Siennicka","year":"2009","unstructured":"Siennicka J, Trzcinska A, Rosinska M, Litwinska B. Seroprevalence of varicella-zoster virus in polish population. Przegl Epidemiol. 2009;63(4):495\u20139.","journal-title":"Przegl Epidemiol"},{"key":"5298_CR13","volume-title":"Ma\u0142y Rocznik Statystyczny Polski","author":"G\u0142\u00f3wny Urz\u0105d Statystyczny","year":"2015","unstructured":"G\u0142\u00f3wny Urz\u0105d Statystyczny. Ma\u0142y Rocznik Statystyczny Polski 2015. Available from: https:\/\/stat.gov.pl\/obszary-tematyczne\/roczniki-statystyczne\/roczniki-statystyczne\/maly-rocznik-statystyczny-polski-2015,1,16.html ."},{"key":"5298_CR14","volume-title":"Medycyna Praktyczna: Ospa wietrzna","author":"B Dubiel","year":"2014","unstructured":"Dubiel B, Duszczyk E. Medycyna Praktyczna: Ospa wietrzna 2014. Available from: http:\/\/www.mp.pl\/szczepienia\/artykuly\/podrecznik\/99866.ospa-wietrzna ."},{"issue":"4 Pt 2","key":"5298_CR15","first-page":"748","volume":"78","author":"AM Arbeter","year":"1986","unstructured":"Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics. 1986;78(4 Pt 2):748\u201356.","journal-title":"Pediatrics"},{"issue":"4","key":"5298_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0022-3476(95)70106-0","volume":"127","author":"PR Krause","year":"1995","unstructured":"Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr. 1995;127(4):518\u201325.","journal-title":"J Pediatr"},{"issue":"9","key":"5298_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0264-410X(91)90189-D","volume":"9","author":"BJ Kuter","year":"1991","unstructured":"Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ, et al. Oka\/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991;9(9):643\u20137.","journal-title":"Vaccine"},{"issue":"22","key":"5298_CR18","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","volume":"310","author":"RE Weibel","year":"1984","unstructured":"Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, et al. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med. 1984;310(22):1409\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"5298_CR19","first-page":"604","volume":"87","author":"CJ White","year":"1991","unstructured":"White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics. 1991;87(5):604\u201310.","journal-title":"Pediatrics"},{"issue":"5","key":"5298_CR20","doi-asserted-by":"publisher","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","volume":"131","author":"R Baxter","year":"2013","unstructured":"Baxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, et al. Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study. Pediatrics. 2013;131(5):e1389\u201396.","journal-title":"Pediatrics"},{"issue":"3\u20134","key":"5298_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","volume":"21","author":"T Nolan","year":"2002","unstructured":"Nolan T, McIntyre P, Roberton D, Descamps D. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Vaccine. 2002;21(3\u20134):281\u20139.","journal-title":"Vaccine"},{"issue":"3","key":"5298_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00431-011-1569-4","volume":"171","author":"M Knuf","year":"2012","unstructured":"Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, et al. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Eur J Pediatr. 2012;171(3):463\u201370.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"5298_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","volume":"25","author":"M Knuf","year":"2006","unstructured":"Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, et al. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Pediatr Infect Dis J. 2006;25(1):12\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"23\u201324","key":"5298_CR24","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1016\/S0264-410X(02)00245-1","volume":"20","author":"YL Lau","year":"2002","unstructured":"Lau YL, Vessey SJ, Chan IS, Lee TL, Huang LM, Lee CY, et al. A comparison of safety, tolerability and immunogenicity of Oka\/Merck varicella vaccine and VARILRIX in healthy children. Vaccine. 2002;20(23\u201324):2942\u20139.","journal-title":"Vaccine"},{"issue":"11","key":"5298_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1651-2227.1991.tb11782.x","volume":"80","author":"T Vesikari","year":"1991","unstructured":"Vesikari T, Ohrling A, Baer M, Delem A, Bogaerts H, Andre FE. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children. Acta Paediatr Scand. 1991;80(11):1051\u20137.","journal-title":"Acta Paediatr Scand"},{"key":"5298_CR26","first-page":"85","volume":"65","author":"M Just","year":"1986","unstructured":"Just M, Berger R, Just V. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. Dev Biol Stand. 1986;65:85\u20138.","journal-title":"Dev Biol Stand"},{"key":"5298_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12889-015-1861-8","volume":"15","author":"O Damm","year":"2015","unstructured":"Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 2015;15:533.","journal-title":"BMC Public Health"},{"issue":"6","key":"5298_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1586\/14760584.7.6.753","volume":"7","author":"MH Rozenbaum","year":"2008","unstructured":"Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vaccines. 2008;7(6):753\u201382.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"5298_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.rpped.2015.12.006","volume":"34","author":"M Hirose","year":"2016","unstructured":"Hirose M, Gilio AE, Ferronato AE, Ragazzi SL. The impact of varicella vaccination on varicella-related hospitalization rates: global data review. Rev Paul Pediatr. 2016;34(3):359\u201366.","journal-title":"Rev Paul Pediatr"},{"issue":"11","key":"5298_CR30","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1099\/jmm.0.000061","volume":"64","author":"C Trucchi","year":"2015","unstructured":"Trucchi C, Gabutti G, Rota MC, Bella A. Burden of varicella in Italy, 2001-2010: analysis of data from multiple sources and assessment of universal vaccination impact in three pilot regions. J Med Microbiol. 2015;64(11):1387\u201394.","journal-title":"J Med Microbiol"},{"key":"5298_CR31","volume-title":"Programu Szczepie\u0144 Ochronnych na rok","author":"Ministra Zdrowia","year":"2016","unstructured":"Ministra Zdrowia. Programu Szczepie\u0144 Ochronnych na rok 2016. Available from: https:\/\/szczepienia.gis.gov.pl\/pliki\/akt.pdf ."},{"issue":"2","key":"5298_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bpobgyn.2014.06.009","volume":"29","author":"LK Weile","year":"2015","unstructured":"Weile LK, Kahn JG, Marseille E, Jensen DM, Damm P, Lohse N. Global cost-effectiveness of GDM screening and management: current knowledge and future needs. Best Pract Res Clin Obstet Gynaecol. 2015;29(2):206\u201324.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"5298_CR33","volume-title":"Varicella Surveillance report","author":"EUVAC.NET","year":"2010","unstructured":"EUVAC.NET. Varicella Surveillance report 2010. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/varicella_report_2010_euvacnet.pdf ."},{"key":"5298_CR34","unstructured":"European Central Bank 2016. Available from: https:\/\/www.ecb.europa.eu\/stats\/policy_and_exchange_rates\/euro_reference_exchange_rates\/html\/eurofxref-graph-pln.en.html . Accessed 12 Feb 2016."},{"issue":"5","key":"5298_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/00006454-199905000-00004","volume":"18","author":"P Fornaro","year":"1999","unstructured":"Fornaro P, Gandini F, Marin M, Pedrazzi C, Piccoli P, Tognetti D, et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian sentinel group on pediatric infectious diseases. Pediatr Infect Dis J. 1999;18(5):414\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"5298_CR36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4161\/hv.9897","volume":"5","author":"A Iseli","year":"2009","unstructured":"Iseli A, Aebi C, Banz K, Brunner M, Schmutz AM, Heininger U. Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland. Hum Vaccin. 2009;5(12):843\u20136.","journal-title":"Hum Vaccin"},{"issue":"5","key":"5298_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1469-0691.2004.00853.x","volume":"10","author":"S Wagenpfeil","year":"2004","unstructured":"Wagenpfeil S, Neiss A, Banz K, Wutzler P. Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect. 2004;10(5):425\u201330.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5298_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/archdischild-2015-308283","volume":"101","author":"S Blumental","year":"2016","unstructured":"Blumental S, Sabbe M, Lepage P, Belgian Group for V. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child. 2016;101(1):16\u201322.","journal-title":"Arch Dis Child"},{"issue":"2","key":"5298_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","volume":"27","author":"JG Liese","year":"2008","unstructured":"Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, Kries R, et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008;27(2):119\u201324.","journal-title":"Pediatr Infect Dis J"},{"key":"5298_CR40","first-page":"226","volume":"2","author":"O Turel","year":"2013","unstructured":"Turel O, Bakir M, Gonen I, Hatipoglu N, Aydogmus C, Hosaf E, et al. Children hospitalized for varicella: complications and cost burden. ViHRI. 2013;2:226\u201330.","journal-title":"ViHRI"},{"issue":"23","key":"5298_CR41","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1016\/S0264-410X(03)00264-0","volume":"21","author":"J Diez-Domingo","year":"2003","unstructured":"Diez-Domingo J, Aristegui J, Calbo F, Gonzalez-Hachero J, Moraga F, Pena Guitian J, et al. Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study. Vaccine. 2003;21(23):3236\u20139.","journal-title":"Vaccine"},{"issue":"2","key":"5298_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00430-002-0123-4","volume":"191","author":"P Wutzler","year":"2002","unstructured":"Wutzler P, Neiss A, Banz K, Goertz A, Bisanz H. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany. Med Microbiol Immunol. 2002;191(2):89\u201396.","journal-title":"Med Microbiol Immunol"},{"issue":"8","key":"5298_CR43","first-page":"E0508116","volume":"10","author":"V Arama","year":"2005","unstructured":"Arama V, Rafila A, Streinu-Cercel A, Pistol A, Bacruban R, Sandu R, et al. Varicella in Romania: epidemiological trends, 1986-2004. Euro Surveill. 2005;10(8):E0508116.","journal-title":"Euro Surveill"},{"issue":"4","key":"5298_CR44","first-page":"282","volume":"3","author":"JC Bramley","year":"2000","unstructured":"Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health. 2000;3(4):282\u20137.","journal-title":"Commun Dis Public Health"},{"issue":"1","key":"5298_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1017\/S0950268806006467","volume":"135","author":"F Dubos","year":"2007","unstructured":"Dubos F, Grandbastien B, Hue V, Hospital Network for Evaluating Management of Common Childhood D, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect. 2007;135(1):131\u20138.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"5298_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00431-005-0043-6","volume":"165","author":"M Theodoridou","year":"2006","unstructured":"Theodoridou M, Laina I, Hadjichristodoulou C, Syriopoulou V. Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction. Eur J Pediatr. 2006;165(4):273\u20134.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"5298_CR47","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1651-2227.2007.00595.x","volume":"97","author":"V Grote","year":"2008","unstructured":"Grote V, von Kries R, Springer W, Hammersen G, Kreth HW, Liese J. Varicella-related deaths in children and adolescents--Germany 2003-2004. Acta Paediatr. 2008;97(2):187\u201392.","journal-title":"Acta Paediatr"},{"issue":"5","key":"5298_CR48","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1469-0691.2007.01706.x","volume":"13","author":"E Grimprel","year":"2007","unstructured":"Grimprel E, Levy C, de La Rocque F, Cohen R, Soubeyrand B, Caulin E, et al. Paediatric varicella hospitalisations in France: a nationwide survey. Clin Microbiol Infect. 2007;13(5):546\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"5298_CR49","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1016\/j.ijid.2012.11.024","volume":"17","author":"E Gowin","year":"2013","unstructured":"Gowin E, Wysocki J, Michalak M. Don't forget how severe varicella can be--complications of varicella in children in a defined polish population. Int J Infect Dis. 2013;17(7):e485\u20139.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"5298_CR50","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0929-693X(04)00410-5","volume":"11","author":"E Mallet","year":"2004","unstructured":"Mallet E, Maitre M, Delalande-Dutilleul L, Marguet C, Mouterde O. Evaluation of varicella complications through a retrospective hospital survey in a paediatric center over 16 years in France. Arch Pediatr. 2004;11(9):1145\u201351.","journal-title":"Arch Pediatr"},{"issue":"10","key":"5298_CR51","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/j.1651-2227.2007.00465.x","volume":"96","author":"S Marchetto","year":"2007","unstructured":"Marchetto S, de Benedictis FM, de Martino M, Versace A, Chiappini E, Bertaine C, et al. Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era. Acta Paediatr. 2007;96(10):1490\u20133.","journal-title":"Acta Paediatr"},{"issue":"6","key":"5298_CR52","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","volume":"164","author":"J Bonhoeffer","year":"2005","unstructured":"Bonhoeffer J, Baer G, Muehleisen B, Aebi C, Nadal D, Schaad UB, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr. 2005;164(6):366\u201370.","journal-title":"Eur J Pediatr"},{"issue":"Suppl 1","key":"5298_CR53","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/jmv.10313","volume":"70","author":"M Brisson","year":"2003","unstructured":"Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol. 2003;70(Suppl 1):S9\u201314.","journal-title":"J Med Virol"},{"issue":"3","key":"5298_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1098-3015(10)64019-3","volume":"6","author":"C Glogowski","year":"2003","unstructured":"Glogowski C, Gierczynski J, Splawinski J. Pin 42: cost of varicella in Poland. Value Health. 2003;6(3):267.","journal-title":"Value Health"},{"key":"5298_CR55","unstructured":"OANDA Corporation 2016. Available from: https:\/\/www.oanda.com\/currency\/average . Accessed 12 Feb 2016."},{"issue":"1","key":"5298_CR56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12879-017-2575-6","volume":"17","author":"Z Meszner","year":"2017","unstructured":"Meszner Z, Molnar Z, Rampakakis E, Yang HK, Kuter BJ, Wolfson LJ. Economic burden of varicella in children 1-12 years of age in Hungary, 2011-2015. BMC Infect Dis. 2017;17(1):495.","journal-title":"BMC Infect Dis"},{"issue":"47\u201348","key":"5298_CR57","doi-asserted-by":"publisher","first-page":"6980","DOI":"10.1016\/j.vaccine.2006.04.051","volume":"24","author":"X Lenne","year":"2006","unstructured":"Lenne X, Diez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B. Economic evaluation of varicella vaccination in Spain: results from a dynamic model. Vaccine. 2006;24(47\u201348):6980\u20139.","journal-title":"Vaccine"},{"issue":"3","key":"5298_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1524-4733.2005.04005.x","volume":"8","author":"L Coudeville","year":"2005","unstructured":"Coudeville L, Brunot A, Szucs TD, Dervaux B. The economic value of childhood varicella vaccination in France and Germany. Value Health. 2005;8(3):209\u201322.","journal-title":"Value Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5298-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-018-5298-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5298-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T23:40:30Z","timestamp":1660779630000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-5298-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5298"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-5298-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"20 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In line with the local regulations, notification to the central Ethics Committee of the Central Register of Clinical Trials in the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products was done for all participating sites. Patient consent was not required, as data were collected retrospectively and provided by the treating physicians in an anonymous manner, identified only by an encrypted patient number.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Jacek Wysocki: paid lecturer for Pfizer and Sanofi, investigator in clinical trials by GSK, Pfizer, Sanofi Pasteur, Actelion and MSD.Ilona Malecka: Paid lecturer for MSD, Sanofi-Aventis.Joanna Stryczynska-Kazubska: Paid lecturer for MSD, Sanofi, Pasteur.Emmanouil Rampakakis: Employee at JSS Medical Research, the CRO hired.Barbara Kuter: Employee and stock shareholder of Merck & Co., Inc.Lara J. Wolfson: Employee and stock shareholder of Merck & Co., Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"410"}}